LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 79.34 | 84.90 | 1160 | 9051 | 0.1282 | 0.4743 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 79.34 | 84.90 | 1196 | 9051 | 0.1321 | 0.4810 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 79.34 | 84.90 | 425 | 9051 | 0.0470 | 0.2701 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 79.34 | 84.90 | 989 | 9051 | 0.1093 | 0.4398 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.05 | 84.90 | 1163 | 8863 | 0.1312 | 0.4774 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.05 | 84.90 | 1202 | 8863 | 0.1356 | 0.4847 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.05 | 84.90 | 407 | 8863 | 0.0459 | 0.2633 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 81.05 | 84.90 | 967 | 8863 | 0.1091 | 0.4373 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.75 | 84.90 | 1161 | 8621 | 0.1347 | 0.4805 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.75 | 84.90 | 1198 | 8621 | 0.1390 | 0.4875 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.75 | 84.90 | 455 | 8621 | 0.0528 | 0.2864 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 82.75 | 84.90 | 1003 | 8621 | 0.1163 | 0.4484 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.45 | 84.90 | 1162 | 8254 | 0.1408 | 0.4862 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.45 | 84.90 | 1194 | 8254 | 0.1446 | 0.4923 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.45 | 84.90 | 431 | 8254 | 0.0522 | 0.2790 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 84.45 | 84.90 | 990 | 8254 | 0.1199 | 0.4506 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.16 | 84.90 | 1166 | 8141 | 0.1432 | 0.4888 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.16 | 84.90 | 1192 | 8141 | 0.1464 | 0.4938 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.16 | 84.90 | 433 | 8141 | 0.0532 | 0.2808 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 86.16 | 84.90 | 1076 | 8141 | 0.1322 | 0.4707 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 84.90 | 1170 | 7680 | 0.1523 | 0.4973 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 84.90 | 1201 | 7680 | 0.1564 | 0.5033 | MN20160318_Q02 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 84.90 | 471 | 7680 | 0.0613 | 0.3017 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 87.86 | 84.90 | 1017 | 7680 | 0.1324 | 0.4653 | MN20160318_Q02 | M17 |
| MCF 10A-H2B-mCherry | Trametinib | 0.31623 | 89.57 | 84.90 | 1153 | 7494 | 0.1538 | 0.4972 | MN20160318_Q02 | D08 |